U.S. Markets closed

L'Oréal S.A. (LRLCY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
41.23+0.06 (+0.15%)
At close: 3:59PM EDT
People also watch
LVMUYBASFYDDAIYBAYRYSIEGY
Full screen
Previous Close41.17
Open41.11
Bid0.00 x 0
Ask0.00 x 0
Day's Range40.95 - 41.23
52 Week Range33.38 - 43.95
Volume37,084
Avg. Volume58,233
Market Cap115.35B
Beta0.52
PE Ratio (TTM)32.76
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.72 (1.74%)
Ex-Dividend Date2017-04-25
1y Target EstN/A
Trade prices are not sourced from all markets
  • L’Oréal SA :LRLCY-US: Earnings Analysis: For the six months ended June 30, 2017 : August 10, 2017
    Capital Cube10 days ago

    L’Oréal SA :LRLCY-US: Earnings Analysis: For the six months ended June 30, 2017 : August 10, 2017

    Categories: Yahoo FinanceGet free summary analysis L’Oréal SA reports financial results for the half-year ended June 30, 2017. We analyze the earnings along side the following peers of L’Oréal SA – Procter & Gamble Company, Revlon, Inc. Class A, Avon Products, Inc., Inter Parfums, Inc., Unilever PLC Sponsored ADR, Sally Beauty Holdings, Inc. and Sanofi Sponsored ADR ... Read more (Read more...)

  • How Valeant Pharmaceuticals Intl Inc (VRX) Stock Can Make a Comeback
    InvestorPlace13 days ago

    How Valeant Pharmaceuticals Intl Inc (VRX) Stock Can Make a Comeback

    There are tons of reason to be skeptical about Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock ahead of its second-quarter fiscal 2017 earnings results before Tuesday’s opening bell. The embattled drugmaker continues to make operational improvements, including divesting various non-core assets to lower debts. Since falling to a 52-week low of $8.31 on April 24, Valeant stock has skyrocketed as much as 118%, reaching $18.17 on July 25.

  • TheStreet.com20 days ago

    Cosmetics Are the Best Investment in Dying Retail Right Now - Here's Why

    It's a beautiful thing, and a beautiful time to buy.